MINIPRESS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Minipress, and what generic alternatives are available?
Minipress is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in MINIPRESS is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minipress
A generic version of MINIPRESS was approved as prazosin hydrochloride by TEVA PHARMS on September 12th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MINIPRESS?
- What are the global sales for MINIPRESS?
- What is Average Wholesale Price for MINIPRESS?
Summary for MINIPRESS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 27 |
Patent Applications: | 1,782 |
Drug Prices: | Drug price information for MINIPRESS |
What excipients (inactive ingredients) are in MINIPRESS? | MINIPRESS excipients list |
DailyMed Link: | MINIPRESS at DailyMed |
Recent Clinical Trials for MINIPRESS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | Phase 1/Phase 2 |
University of Washington | Phase 4 |
Fast Grants | Phase 2 |
US Patents and Regulatory Information for MINIPRESS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-001 | Jan 29, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MINIPRESS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MINIPRESS
See the table below for patents covering MINIPRESS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 146499 | ⤷ Sign Up | |
U.S.S.R. | 644387 | METHOD OF OBTAINING CRYSTALLINE A-FORM OF 2-/4-(2-FUROYL)-PIPERAZIN-1-YL/-4-AMINO-6,7-DIMETHOXYQUINAZOLINEHYDROCHLORIDE | ⤷ Sign Up |
Hong Kong | 30881 | NOVEL CRYSTALLINE FORMS OF PRAZOSIN HYDROCHLORIDE | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |